OA05.04 Sacituzumab Govitecan + Pembrolizumab in 1L Metastatic Non-Small Cell Lung Cancer: Preliminary Results of the EVOKE-02 Study
Byoung Chul Cho, M.C. Dols, Rubén Cabanillas, David Vicente Baz, J. Fuentes Pradera, Salvatore Grisanti, A.E. Gabayan, K.H. Lee, E.K. Cho, Sabeen Mekan, F. Safavi, N. Fernando, Michael Chisamore, Martin Reck
Topics & Concepts
PembrolizumabMedicineLung cancerOncologyMonoclonal antibodyInternal medicineFirst lineCancerImmunotherapyAntibodyImmunologyCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsImmunotherapy and Immune Responses